and not a generic "immunoassay" method because this guideline is based on a report comparing RIA and tandem mass spectrometry (3) .
PubMed citation number 2 is a more recent report demonstrating analytical similarity of an extraction-RIA method for measuring testosterone compared to mass spectrometry (4) .
PubMed citation number 3 is not a guideline, per say, and is not relevant (5) .
PubMed citation number 4 describes the CDC's efforts to standardize testosterone measurements, recognizing the limitations of current immunoassays (6) . While illustrating the advantages of mass spectrometry for the measurement of testosterone, the authors point out that for testosterone levels <100 ng/dL, variations of +40% to −40% are observed when mass spectrometry and immunoassay testosterone measurements are compared.
PubMed citation number 5 concerns saliva and is not relevant to this discussion (7) .
PubMed citation number 6 makes no recommendations about the method of testosterone measurement in polycystic ovarian syndrome (8) .
It would be reasonable to state that measuring low concentrations of testosterone by immunoassay is problematic under any circumstance (9) . Many experts would then recommend that testosterone in women and in children (and possibly in hypogonadal men) should always be measured by mass spectrometry (and this is the policy at my institution). A review of 3 major reference laboratories indicated that all 3 measured total testosterone by mass spectrometry in women and children. One laboratory also measured total testosterone by mass spectrometry in hypogonadal men, and still another laboratory reportedly performs all of their total testosterone measurements by mass spectrometry. Although total testosterone measurements are considered controversial, free testosterone measurements are even more debated.
This topic is beyond the scope of the article by Heijboer et al. (1); however, many experts recommend that free testosterone should be calculated from the measurement of sex hormone-binding globulin and total testosterone (10, 11) .
I am hopeful that continued efforts by the CDC will provide firm guidance that testosterone in women and children (and possibly in hypogonadal men) should always be measured by mass spectrometry (12) . I will stay tuned for the rest of this story. 
